Literature DB >> 18809670

A dopamine D2 receptor mutant capable of G protein-mediated signaling but deficient in arrestin binding.

Hongxiang Lan1, Yong Liu, Michal I Bell, Vsevolod V Gurevich, Kim A Neve.   

Abstract

Arrestins mediate G protein-coupled receptor desensitization, internalization, and signaling. Dopamine D(2) and D(3) receptors have similar structures but distinct characteristics of interaction with arrestins. The goals of this study were to compare arrestin-binding determinants in D(2) and D(3) receptors other than phosphorylation sites and to create a D(2) receptor that is deficient in arrestin binding. We first assessed the ability of purified arrestins to bind to glutathione transferase (GST) fusion proteins containing the receptor third intracellular loops (IC3). Arrestin3 bound to IC3 of both D(2) and D(3) receptors, with the affinity and localization of the binding site indistinguishable between the receptor subtypes. Mutagenesis of the GST-IC3 fusion proteins identified an important determinant of the binding of arrestin3 in the N-terminal region of IC3. Alanine mutations of this determinant (IYIV212-215) in the full-length D(2) receptor generated a signaling-biased receptor with intact ligand binding and G-protein coupling and activation, but deficient in receptor-mediated arrestin3 translocation to the membrane, agonist-induced receptor internalization, and agonist-induced desensitization in human embryonic kidney 293 cells. This mutation also decreased arrestin-dependent activation of extracellular signal-regulated kinases. The finding that nonphosphorylated D(2)-IC3 and D(3)-IC3 have similar affinity for arrestin is consistent with previous suggestions that the differential effects of D(2) and D(3) receptor activation on membrane translocation of arrestin and receptor internalization are due, at least in part, to differential phosphorylation of the receptors. In addition, these results imply that the sequence IYIV212-215 at the N terminus of IC3 of the D(2) receptor is a key element of the arrestin binding site.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18809670      PMCID: PMC2606918          DOI: 10.1124/mol.108.050534

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  48 in total

1.  Direct and differential interaction of beta-arrestins with the intracellular domains of different opioid receptors.

Authors:  B Cen; Y Xiong; L Ma; G Pei
Journal:  Mol Pharmacol       Date:  2001-04       Impact factor: 4.436

Review 2.  Evolving concepts in G protein-coupled receptor endocytosis: the role in receptor desensitization and signaling.

Authors:  S S Ferguson
Journal:  Pharmacol Rev       Date:  2001-03       Impact factor: 25.468

3.  Generation of deletion and point mutations with one primer in a single cloning step.

Authors:  O Makarova; E Kamberov; B Margolis
Journal:  Biotechniques       Date:  2000-11       Impact factor: 1.993

4.  Differential regulation of the dopamine D2 and D3 receptors by G protein-coupled receptor kinases and beta-arrestins.

Authors:  K M Kim; K J Valenzano; S R Robinson; W D Yao; L S Barak; M G Caron
Journal:  J Biol Chem       Date:  2001-07-25       Impact factor: 5.157

5.  Crystal structure of beta-arrestin at 1.9 A: possible mechanism of receptor binding and membrane Translocation.

Authors:  M Han; V V Gurevich; S A Vishnivetskiy; P B Sigler; C Schubert
Journal:  Structure       Date:  2001-09       Impact factor: 5.006

Review 6.  Classical and new roles of beta-arrestins in the regulation of G-protein-coupled receptors.

Authors:  K L Pierce; R J Lefkowitz
Journal:  Nat Rev Neurosci       Date:  2001-10       Impact factor: 34.870

7.  Beta-arrestin 2: a receptor-regulated MAPK scaffold for the activation of JNK3.

Authors:  P H McDonald; C W Chow; W E Miller; S A Laporte; M E Field; F T Lin; R J Davis; R J Lefkowitz
Journal:  Science       Date:  2000-11-24       Impact factor: 47.728

8.  Arrestin binding to the M(2) muscarinic acetylcholine receptor is precluded by an inhibitory element in the third intracellular loop of the receptor.

Authors:  K B Lee; J A Ptasienski; R Pals-Rylaarsdam; V V Gurevich; M M Hosey
Journal:  J Biol Chem       Date:  2000-03-31       Impact factor: 5.157

9.  Association of beta-Arrestin 1 with the type 1A angiotensin II receptor involves phosphorylation of the receptor carboxyl terminus and correlates with receptor internalization.

Authors:  H Qian; L Pipolo; W G Thomas
Journal:  Mol Endocrinol       Date:  2001-10

10.  An intracellular loop 2 amino acid residue determines differential binding of arrestin to the dopamine D2 and D3 receptors.

Authors:  Hongxiang Lan; Martha M Teeter; Vsevolod V Gurevich; Kim A Neve
Journal:  Mol Pharmacol       Date:  2008-09-26       Impact factor: 4.436

View more
  28 in total

1.  Receptor conformations involved in dopamine D(2L) receptor functional selectivity induced by selected transmembrane-5 serine mutations.

Authors:  J Corey Fowler; Supriyo Bhattacharya; Jonathan D Urban; Nagarajan Vaidehi; Richard B Mailman
Journal:  Mol Pharmacol       Date:  2012-03-13       Impact factor: 4.436

2.  Dopamine D(2) receptor function is compromised in the brain of the methionine sulfoxide reductase A knockout mouse.

Authors:  Derek B Oien; Andrea N Ortiz; Alexander G Rittel; Rick T Dobrowsky; Michael A Johnson; Beth Levant; Stephen C Fowler; Jackob Moskovitz
Journal:  J Neurochem       Date:  2010-03-31       Impact factor: 5.372

Review 3.  Dopamine D2 autoreceptor interactome: Targeting the receptor complex as a strategy for treatment of substance use disorder.

Authors:  Rong Chen; Mark J Ferris; Shiyu Wang
Journal:  Pharmacol Ther       Date:  2020-05-27       Impact factor: 12.310

4.  Discovery and characterization of a G protein-biased agonist that inhibits β-arrestin recruitment to the D2 dopamine receptor.

Authors:  R Benjamin Free; Lani S Chun; Amy E Moritz; Brittney N Miller; Trevor B Doyle; Jennie L Conroy; Adrian Padron; Julie A Meade; Jingbo Xiao; Xin Hu; Andrés E Dulcey; Yang Han; Lihua Duan; Steve Titus; Melanie Bryant-Genevier; Elena Barnaeva; Marc Ferrer; Jonathan A Javitch; Thijs Beuming; Lei Shi; Noel T Southall; Juan J Marugan; David R Sibley
Journal:  Mol Pharmacol       Date:  2014-04-22       Impact factor: 4.436

5.  Mutation of three residues in the third intracellular loop of the dopamine D2 receptor creates an internalization-defective receptor.

Authors:  Cecilea C Clayton; Prashant Donthamsetti; Nevin A Lambert; Jonathan A Javitch; Kim A Neve
Journal:  J Biol Chem       Date:  2014-10-21       Impact factor: 5.157

6.  Identification of two functionally distinct endosomal recycling pathways for dopamine D₂ receptor.

Authors:  Yun Li; Brittany D Roy; Wei Wang; Li Zhang; Lifeng Zhang; Stephen B Sampson; Yupeng Yang; Da-Ting Lin
Journal:  J Neurosci       Date:  2012-05-23       Impact factor: 6.167

Review 7.  Many faces of the GPCR-arrestin interaction.

Authors:  Kiae Kim; Ka Young Chung
Journal:  Arch Pharm Res       Date:  2020-08-14       Impact factor: 4.946

8.  RGS2 modulates the activity and internalization of dopamine D2 receptors in neuroblastoma N2A cells.

Authors:  Deborah J Luessen; Tyler P Hinshaw; Haiguo Sun; Allyn C Howlett; Glen Marrs; Brian A McCool; Rong Chen
Journal:  Neuropharmacology       Date:  2016-08-12       Impact factor: 5.250

Review 9.  Agonist-selective signaling of G protein-coupled receptor: mechanisms and implications.

Authors:  Hui Zheng; Horace H Loh; Ping-Yee Law
Journal:  IUBMB Life       Date:  2010-02       Impact factor: 3.885

10.  An intracellular loop 2 amino acid residue determines differential binding of arrestin to the dopamine D2 and D3 receptors.

Authors:  Hongxiang Lan; Martha M Teeter; Vsevolod V Gurevich; Kim A Neve
Journal:  Mol Pharmacol       Date:  2008-09-26       Impact factor: 4.436

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.